Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Electrically Altering Children’s Brains: Psychiatry’s Latest Treatment Fad
Via Press Release Distribution Service
Exposures Product Safety
Hautuki Introduces Safe and Easy Supplements: Skin-Friendly, Hassle-Free Patch Solutions
Via AB Newswire
Exposures Product Safety
Hautuki, Safe and Easy Supplements: Gentle on Skin, Hassle-Free Patch
Via AB Newswire
Exposures Product Safety
Ascendis Pharma Zips Higher After FDA Approves Embattled Thyroid Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers ASND
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Via Benzinga
Exposures Product Safety
Tickers HUMA
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
Via Benzinga
Exposures Product Safety
Tickers SCPH
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
Via Newsfile
Exposures Product Safety
Tickers AEMD NVS
Adaptimmune Reports Q2 2024 Financial and Business Updates
Via Newsfile
Exposures Product Safety
Tickers ADAP
FDA Breakthrough Device That Can Reverse Alzheimer’s Cognitive Decline May Well Increase Human Life Span
Via Get News
Exposures Product Safety
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
Via Benzinga
Exposures Product Safety
American Kratom Association Welcomes the FDA Withdrawal of Deeply Flawed Risk/Safety Data Collection and Study on Psychedelic and Kratom Use
Via EZ Newswire
Exposures Product Safety
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
Via Benzinga
Exposures Product Safety
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Via Benzinga
Exposures Product Safety
Tickers SNY SPRY
Analysis Shows Recalls Woefully Slow in Removing Potentially Contaminated Cannabis from Circulation
Via CannabisNewsWire
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Tickers VRNOF
Analysis Shows Recalls Woefully Slow in Removing Potentially Contaminated Cannabis from Circulation
Via Investor Brand Network
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Anaheim White House Celebrates 37th Anniversary With Free Prosecco August 21
Via Press Release Distribution Service
Topics Economy Product Recall
Exposures Economy Legal Product Safety
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection
Via Benzinga
Exposures Product Safety
Tickers CTXR
Emerging Giants: AI-Driven Innovators Under $2 Set to Transform Markets INBS, PRSO, LPSN, PACB, NINE
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers INBS PRSO
Why Choose Capsule Tablet Metal Detector in Pharmaceutical Industry?
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
Via Benzinga
Exposures Product Safety
Tickers NVS
JD.JUNE’s Bodysuits for Bosses: Revolutionizes Corporate America
Via Syndication Cloud
Topics Product Recall
Exposures Legal Product Safety
BMW Recalls Over 105K Vehicles In U.S. Over Fire Risks Due To Overheating Starter Motor
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BMWYY
3 Biotech Stocks With Promising Drug Pipelines: August 2024
Via InvestorPlace
Exposures Product Safety
Tickers BMY BNTX REGN
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
Via Benzinga
Exposures Product Safety
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
Via Benzinga
Exposures Product Safety
Tickers EXEL
Novo Nordisk Withdraws Wegovy FDA Heart Failure Submission, Terminates Development Of Two Early Stage Assets
Via Benzinga
Exposures Product Safety
Tickers NVO
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Amgen's MariTide Weight Loss Potential: Stock Outlook
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers AMGN LLY NVO XLV
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.